Welcome to the UNCLCN Learning Portal

The UNCLCN Learning Portal contains oncology education videos presented by experts in North Carolina and throughout the US.
View our Live Webinars and Self-Paced Online Courses to earn free continuing education credit!

Free Continuing Education credits are available for:
Physicians, Nurses, Pharmacists, Pharmacy Technicians, Radiologic Technologists, and Certified Tumor Registrars

Upcoming Live Webinar

The Selective Use of Radiation in Solid Malignancies
 

The Selective Use of Radiation in Solid Malignancies

Kevin Pearlstein, MD

May 22 • 12:00 - 1:00 PM EST

Radiation therapy is an integral part of cancer treatment across many disease sites, but the locoregional control benefits must be weighed against the potential toxicities. During this webinar, Kevin Pearlstein, MD, will review the role of radiation in cancer care including basic radiobiologic principles, logistics, and toxicities. He will discuss several recent studies examining the omission of radiation for different solid malignancies and review strategies to identify patients who will benefit the most from radiation.

Register for this webinar

View more Live Webinars

Featured Self-Paced Online Course

Exercise and Wellness as Part of the Cancer Experience
Research to Practice
CME - NCPD/CNE - ACPE - ASRT - CTR
 

Meira Epplein, PhD
Katherine Garman, MD

 

 

Ready to Learn!

Please take a look at all our educational offerings. Continuing Education credits are available for healthcare providers in select webinars.

image

Live Webinars

image

Self-Paced Online Courses

image

All Webinars

image

More about us


Sign up for our newsletter or follow us on social media!

imageimageimageimageimageimage

 

Recent Courses

  • NC Community College Course
  • NC Community College Oncology
This course contains twelve classes, each one focused on a different topic concerning cancer:
    • 12.00 Participation
  • Self-Paced, Online Courses
  • Research to Practice
Jose Gaston Guillem, MD, MPH, MBA, will describe how at UNC Medical Center a team of experts carefully reviews each individual patient during a Weekly GI Tumor Board and collaboratively develop a treatment plan which defines the specific timing and sequence of care for each patient.
    • 1.00 ACPE Pharmacist
    • 1.00 ACPE Pharmacy Tech
    • 1.00 ASRT
    • 1.00 CTR
    • 1.00 Participation
  • Self-Paced, Online Courses
  • Advanced Practice Provider
Taking a deeper dive into the most common oncologic emergencies facing oncology patients. We will discuss the clinical manifestations, diagnosis, treatment, and prevention of Neutropenic Fever, Tumor Lysis Syndrome, and Cord Compression. These topics are good refreshers for APPs practicing in primary care, urgent, emergency medicine, hematology/oncology, and inpatient medicine.
    • 1.00 NCPD/CNE
    • 1.00 Participation
  • Self-Paced, Online Courses
  • NC Community College Oncology
Melanie N. Allard, DNP, APRN, FNP-BC, AGAC-NP (student), will review basic gastrointestinal tract anatomy and discuss gastrointestinal cancer(s), workup, and treatment. She will differentiate between each disease type specifically with signs/symptoms, statistics, and management, and help attendees to recognize common side effects of treatment and management of symptoms.
    • 1.00 Participation
  • Self-Paced, Online Courses
  • Advanced Practice Provider
Patients undergoing treatment for cancer utilize many medications that have relevant drug-gene interactions. The use of pharmacogenomic testing can assist with drug selection, drug dosing, and the development of personalized medication monitoring plans. Amber Cipriani, PharmD, BCOP, will describe some common examples of drug-gene interactions relevant to oncology. She will also discuss current efforts to expand the use of pharmacogenomic testing into current clinical practice.
    • 1.00 AMA PRA Category 1 Credit
    • 1.00 NCPD/CNE
    • 1.00 Participation
  • NC Community College Course
  • NC Community College Oncology
This course contains two webinars, each one focused on caring for patients with either a blood or a skin cancer:
    • 1.00 Participation

Pages